CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 259 filers reported holding CONMED CORP in Q3 2021. The put-call ratio across all filers is 3.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,906 | +18.3% | 105 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $9,219 | +207.3% | 104 | +173.7% | 0.00% | – |
| Q3 2022 | $3,000 | -75.0% | 38 | -70.3% | 0.00% | -100.0% |
| Q2 2022 | $12,000 | -42.9% | 128 | -12.9% | 0.00% | -33.3% |
| Q1 2022 | $21,000 | +5.0% | 147 | +2.8% | 0.00% | 0.0% |
| Q4 2021 | $20,000 | +33.3% | 143 | +27.7% | 0.00% | +50.0% |
| Q3 2021 | $15,000 | -11.8% | 112 | -8.2% | 0.00% | -33.3% |
| Q2 2021 | $17,000 | +30.8% | 122 | +22.0% | 0.00% | -50.0% |
| Q1 2021 | $13,000 | +30.0% | 100 | +11.1% | 0.01% | +50.0% |
| Q4 2020 | $10,000 | +150.0% | 90 | +66.7% | 0.00% | +100.0% |
| Q3 2020 | $4,000 | +33.3% | 54 | +45.9% | 0.00% | +100.0% |
| Q2 2020 | $3,000 | +200.0% | 37 | +48.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 25 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $2,000 | – | 25 | +316.7% | 0.00% | – |
| Q4 2018 | $0 | – | 6 | +20.0% | 0.00% | – |
| Q3 2018 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 190,000 | $24,858,000 | 3.57% |
| Ranger Investment Management | 253,789 | $33,203,000 | 1.77% |
| EARNEST PARTNERS LLC | 1,603,130 | $209,737,000 | 1.28% |
| Penn Capital Management Company, LLC | 92,086 | $12,048,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,492,419 | $195,253,000 | 0.94% |
| MOODY ALDRICH PARTNERS LLC | 53,257 | $6,968,000 | 0.88% |
| Hood River Capital Management LLC | 215,384 | $28,179,000 | 0.87% |
| OAK RIDGE INVESTMENTS LLC | 71,880 | $9,404,000 | 0.83% |
| WAFRA INC. | 138,542 | $18,125,000 | 0.66% |
| EPIQ PARTNERS, LLC | 10,463 | $1,369,000 | 0.63% |